ESC 365 - Grayzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%

EHRA Premium Access

Grayzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%

Session: Oral abstract session - Atrial fibrillation and arrhythmias

Topic: Device Treatment

Speaker: Doctor A. Zegard (Birmingham, GB)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Abbasin Zegard

Aston University, Birmingham (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

12 more presentations in this session

Clinical and electrophysiological characteristics of extra-pulmonary vein triggers in patients who underwent catheter ablation for atrial fibrillation

Speaker: Doctor T. Hwang (Seoul, KR)

Atrial fibrillation detected at screening is not a benign condition - a comparison of clinical outcomes in screen-detected vs. hospital-detected atrial fibrillation

Speaker: Mr V. Zwartkruis (Groningen, NL)

Personalized atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness. the ablate by-law single center study.

Speaker: Doctor C. Teres (Lausanne, CH)

Atrial fibrillation in the young: clinical characteristics, predictors of new onset and outcomes

Speaker: Doctor A. Segev (Ramat Gan, IL)

Heterogeneity of right ventricular refractory period: a novel prognostic predictor in type-1 Brugada

Speaker: Mr L. Teresi (Messina, IT)

Access the full session

Oral abstract session - Atrial fibrillation and arrhythmias

Speakers: Doctor A. Zegard, Doctor T. Hwang, Mr V. Zwartkruis, Doctor C. Teres, Doctor A. Segev...

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources